Page last updated: 2024-11-02

pioglitazone and Psoriasis Arthropathica

pioglitazone has been researched along with Psoriasis Arthropathica in 2 studies

Pioglitazone: A thiazolidinedione and PPAR GAMMA agonist that is used in the treatment of TYPE 2 DIABETES MELLITUS.
pioglitazone : A member of the class of thiazolidenediones that is 1,3-thiazolidine-2,4-dione substituted by a benzyl group at position 5 which in turn is substituted by a 2-(5-ethylpyridin-2-yl)ethoxy group at position 4 of the phenyl ring. It exhibits hypoglycemic activity.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Takahara, M1
Shiraiwa, T1
Kaneto, H1
Yasuda, T1
Kuroda, A1
Sakamoto, F1
Naka, T1
Miyashita, K1
Sakamoto, K1
Matsuoka, T1
Shimomura, I1
Matsuhisa, M1
Bongartz, T1
Coras, B1
Vogt, T1
Schölmerich, J1
Müller-Ladner, U1

Trials

1 trial available for pioglitazone and Psoriasis Arthropathica

ArticleYear
Treatment of active psoriatic arthritis with the PPARgamma ligand pioglitazone: an open-label pilot study.
    Rheumatology (Oxford, England), 2005, Volume: 44, Issue:1

    Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Arthritis, Psoriatic; Drug The

2005

Other Studies

1 other study available for pioglitazone and Psoriasis Arthropathica

ArticleYear
Improvement of psoriatic arthritis by pioglitazone treatment in a type 2 diabetic patient.
    Diabetes research and clinical practice, 2010, Volume: 90, Issue:1

    Topics: Arthritis, Psoriatic; C-Reactive Protein; Diabetes Mellitus, Type 2; Female; Glycated Hemoglobin; Hu

2010